Literature DB >> 17431671

Predominant expression of OLIG2 over ID2 in oligodendroglial tumors.

Shuji Mikami1, Yuichi Hirose, Kazunari Yoshida, Takeshi Kawase, Akiko Ohnishi, Kazuo Nagashima, Makio Mukai, Yasunori Okada, Eiji Ikeda.   

Abstract

OLIG2 is a basic helix-loop-helix transcription factor regulating the generation of oligodendrocytes from neural progenitor cells, and the function of OLIG2 is inhibited posttranslationally through the interaction with ID2. This study aims to examine if the analysis of OLIG2 and ID2 expression in glioma tissues helps the differential diagnosis of chemosensitive oligodendroglial tumors from astrocytic tumors. Expression levels of OLIG2 and ID2 in 11 oligodendroglial and 27 astrocytic tumors were analyzed by reverse transcription-polymerase chain reaction (RT-PCR), real-time quantitative PCR, and immunohistochemistry. The mean expression level of OLIG2 was higher in oligodendroglial tumors than astrocytic tumors, but some astrocytic tumors showed high OLIG2 expression, indicating that OLIG2 cannot be an independent marker of oligodendroglial tumors. No significant difference was observed between ID2 expression in oligodendroglial tumors and astrocytic tumors. It was notable that OLIG2 expression was predominant over ID2 expression in oligodendroglial tumors, while ID2 expression was predominant over OLIG2 expression in astrocytic tumors. Comparative genomic hybridization revealed that gliomas with loss on chromosome 1p, which is closely associated with chemosensitivity, also showed the predominant expression of OLIG2 over ID2. These results indicate that the immunohistochemical study on the relative expression level of OLIG2 to ID2 can be a useful screening for oligodendroglial tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17431671     DOI: 10.1007/s00428-007-0394-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  23 in total

Review 1.  Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment.

Authors:  D Fortin; G J Cairncross; R R Hammond
Journal:  Neurosurgery       Date:  1999-12       Impact factor: 4.654

2.  Specific requirements of sonic hedgehog signaling during oligodendrocyte development.

Authors:  Saeock Oh; Xi Huang; Chin Chiang
Journal:  Dev Dyn       Date:  2005-11       Impact factor: 3.780

3.  Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors.

Authors:  Dmitri A A Vandeputte; Dirk Troost; Sieger Leenstra; Helen Ijlst-Keizers; Marja Ramkema; D Andries Bosch; Frank Baas; Nab K Das; Eleonora Aronica
Journal:  Glia       Date:  2002-06       Impact factor: 7.452

4.  Sonic hedgehog--regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system.

Authors:  Q R Lu; D Yuk; J A Alberta; Z Zhu; I Pawlitzky; J Chan; A P McMahon; C D Stiles; D H Rowitch
Journal:  Neuron       Date:  2000-02       Impact factor: 17.173

5.  Grade II astrocytomas are subgrouped by chromosome aberrations.

Authors:  Yuichi Hirose; Kenneth D Aldape; Susan Chang; Kathleen Lamborn; Mitchel S Berger; Burt G Feuerstein
Journal:  Cancer Genet Cytogenet       Date:  2003-04-01

6.  Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.

Authors:  Elize M Biemond-ter Stege; Johan M Kros; Hein G de Bruin; R H Enting; Irene van Heuvel; Leendert H J Looijenga; Carin D D van der Rijt; Peter A E Sillevis Smitt; Martin J van den Bent
Journal:  Cancer       Date:  2005-02-15       Impact factor: 6.860

Review 7.  Anaplastic astrocytoma: diagnosis, prognosis, and management.

Authors:  Siew Ju See; Mark R Gilbert
Journal:  Semin Oncol       Date:  2004-10       Impact factor: 4.929

8.  Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas.

Authors:  Akiko Ohnishi; Hirofumi Sawa; Masumi Tsuda; Yutaka Sawamura; Tomoo Itoh; Yoshinobu Iwasaki; Kazuo Nagashima
Journal:  J Neuropathol Exp Neurol       Date:  2003-10       Impact factor: 3.685

9.  Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation.

Authors:  Jayshree Samanta; John A Kessler
Journal:  Development       Date:  2004-07-27       Impact factor: 6.868

10.  Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

Authors:  J G Cairncross; K Ueki; M C Zlatescu; D K Lisle; D M Finkelstein; R R Hammond; J S Silver; P C Stark; D R Macdonald; Y Ino; D A Ramsay; D N Louis
Journal:  J Natl Cancer Inst       Date:  1998-10-07       Impact factor: 13.506

View more
  3 in total

1.  Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms.

Authors:  Anne-Laure Trépant; Christelle Bouchart; Sandrine Rorive; Sébastien Sauvage; Christine Decaestecker; Pieter Demetter; Isabelle Salmon
Journal:  Tumour Biol       Date:  2014-11-12

2.  Elevated Id2 expression results in precocious neural stem cell depletion and abnormal brain development.

Authors:  Hee Jung Park; Mingi Hong; Roderick T Bronson; Mark A Israel; Wayne N Frankel; Kyuson Yun
Journal:  Stem Cells       Date:  2013-05       Impact factor: 6.277

3.  A distinct spectrum of copy number aberrations in pediatric high-grade gliomas.

Authors:  Dorine A Bax; Alan Mackay; Suzanne E Little; Diana Carvalho; Marta Viana-Pereira; Narinder Tamber; Anita E Grigoriadis; Alan Ashworth; Rui M Reis; David W Ellison; Safa Al-Sarraj; Darren Hargrave; Chris Jones
Journal:  Clin Cancer Res       Date:  2010-06-22       Impact factor: 12.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.